VOR
Price
$2.05
Change
-$0.16 (-7.24%)
Updated
Jul 21 closing price
Capitalization
256.17M
16 days until earnings call
XNCR
Price
$9.10
Change
+$0.13 (+1.45%)
Updated
Jul 21 closing price
Capitalization
647.65M
8 days until earnings call
Interact to see
Advertisement

VOR vs XNCR

Header iconVOR vs XNCR Comparison
Open Charts VOR vs XNCRBanner chart's image
Vor Biopharma
Price$2.05
Change-$0.16 (-7.24%)
Volume$5.8M
Capitalization256.17M
Xencor
Price$9.10
Change+$0.13 (+1.45%)
Volume$503.95K
Capitalization647.65M
VOR vs XNCR Comparison Chart in %
Loading...
VOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VOR vs. XNCR commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VOR is a StrongBuy and XNCR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (VOR: $2.05 vs. XNCR: $9.10)
Brand notoriety: VOR and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VOR: 24% vs. XNCR: 64%
Market capitalization -- VOR: $256.17M vs. XNCR: $647.65M
VOR [@Biotechnology] is valued at $256.17M. XNCR’s [@Biotechnology] market capitalization is $647.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VOR’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • VOR’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both VOR and XNCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VOR’s TA Score shows that 5 TA indicator(s) are bullish while XNCR’s TA Score has 5 bullish TA indicator(s).

  • VOR’s TA Score: 5 bullish, 5 bearish.
  • XNCR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than VOR.

Price Growth

VOR (@Biotechnology) experienced а -14.23% price change this week, while XNCR (@Biotechnology) price change was +2.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.39%. For the same industry, the average monthly price growth was +15.71%, and the average quarterly price growth was +33.77%.

Reported Earning Dates

VOR is expected to report earnings on Aug 07, 2025.

XNCR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($648M) has a higher market cap than VOR($256M). VOR YTD gains are higher at: 84.685 vs. XNCR (-60.400). VOR has higher annual earnings (EBITDA): -118.74M vs. XNCR (-161.68M). XNCR has more cash in the bank: 470M vs. VOR (60M). VOR has less debt than XNCR: VOR (30.8M) vs XNCR (67.8M). XNCR has higher revenues than VOR: XNCR (127M) vs VOR (0).
VORXNCRVOR / XNCR
Capitalization256M648M40%
EBITDA-118.74M-161.68M73%
Gain YTD84.685-60.400-140%
P/E RatioN/AN/A-
Revenue0127M-
Total Cash60M470M13%
Total Debt30.8M67.8M45%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VORXNCR
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
76%
Momentum
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 5 days ago
68%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 5 days ago
85%
Advances
ODDS (%)
Bullish Trend 16 days ago
80%
Bullish Trend 6 days ago
72%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 12 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
79%
Aroon
ODDS (%)
Bullish Trend 5 days ago
79%
Bearish Trend 5 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
VOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNTCF5.930.08
+1.44%
DENTALCORP HLDGS LTD
BFNH0.75N/A
N/A
BioForce Nanosciences Holdings, Inc.
BKBLF0.05N/A
N/A
Magnetic North Acquisition Corp.
DBOEY30.52-0.06
-0.20%
Deutsche Boerse AG
FBASF1.43-0.03
-2.05%
Deutsche Bank Mexico SA Real Estate Investment Trust

VOR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VOR has been loosely correlated with QSI. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if VOR jumps, then QSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VOR
1D Price
Change %
VOR100%
-7.24%
QSI - VOR
36%
Loosely correlated
-2.27%
CVAC - VOR
35%
Loosely correlated
+0.19%
NTLA - VOR
33%
Loosely correlated
+4.73%
XNCR - VOR
32%
Poorly correlated
+1.45%
ALEC - VOR
31%
Poorly correlated
+1.89%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with CRNX. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+1.45%
CRNX - XNCR
61%
Loosely correlated
-0.51%
SYRE - XNCR
56%
Loosely correlated
+0.37%
BEAM - XNCR
56%
Loosely correlated
+1.35%
KRYS - XNCR
56%
Loosely correlated
+0.41%
IDYA - XNCR
55%
Loosely correlated
+1.02%
More